SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-034341
Filing Date
2023-12-13
Accepted
2023-12-13 16:44:44
Documents
15
Period of Report
2023-12-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnpx20231121_8k.htm   iXBRL 8-K 33238
2 EXHIBIT 1.1 ex_599777.htm EX-1.1 238361
3 EXHIBIT 5.1 ex_599778.htm EX-5.1 8685
  Complete submission text file 0001437749-23-034341.txt   474470

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20231212.xsd EX-101.SCH 3410
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20231212_def.xml EX-101.DEF 11805
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20231212_lab.xml EX-101.LAB 15849
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20231212_pre.xml EX-101.PRE 12020
9 EXTRACTED XBRL INSTANCE DOCUMENT gnpx20231121_8k_htm.xml XML 2637
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

IRS No.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38244 | Film No.: 231484553
SIC: 2834 Pharmaceutical Preparations